Tower Research Capital (TRC)’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122K | Buy |
|
|||||
|
2025
Q4 | $22.8K | Sell |
|
|||||
|
2025
Q3 | $789K | Buy |
|
|||||
|
2025
Q2 | $390K | Sell |
|
|||||
|
2025
Q1 | $534K | Buy |
|
|||||
|
2024
Q4 | $36.7K | Buy |
|
|||||
|
2024
Q3 | $31.7K | Sell |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2024
Q1 | $144K | Buy |
|
|||||
|
2023
Q4 | $134K | Buy |
|
|||||
|
2023
Q3 | $63.4K | Sell |
|
|||||
|
2023
Q2 | $138K | Buy |
|
|||||
|
2023
Q1 | $100K | Buy |
|
|||||
|
2022
Q4 | $18K | Sell |
|
|||||
|
2022
Q3 | $164K | Buy |
|
|||||
|
2022
Q2 | $39K | Buy |
|
|||||
|
2022
Q1 | $21K | Sell |
|
|||||
|
2021
Q4 | $70K | Buy |
|
|||||
|
2021
Q3 | $14K | Sell |
|
|||||
|
2021
Q2 | $91K | Buy |
|